Compare American Well Corp (AMWL) vs Goldman Sachs Group Inc (GS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
American Well Corp vs Goldman Sachs Group Inc — how do they compare? American Well Corp trades at $9.89 (market cap $165.58M), while Goldman Sachs Group Inc trades at $1,058 (market cap $311.29B). The key difference: Goldman Sachs Group Inc is far larger — about 1880× American Well Corp's market cap, and Goldman Sachs Group Inc pays a 1.71% dividend while American Well Corp pays none. Which is the better fit depends on your goals.
| AMWL | GS | |
|---|---|---|
Market Cap | $165.58M | $311.29B |
Sector | Health | Financials |
52-Week High | $9.91 | $1.11K |
52-Week Low | $3.78 | $700.41 |
Enterprise Value | -$9.66M | — |
Volume | — | 2,592,735 |
Dividend Yield | — | 1.71% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMWL trades at $9.91, up 8.66% today, with bullish technical signals and positive momentum. The company shows improving financial trends with declining losses and strong gross margins of 52.9%, though it remains unprofitable with a -37.02% net margin. Recent news highlights Amazon's appointment of Amwell's co-founder to lead its healthcare unit, signaling industry validation.
While AMWL shows operational improvement and attractive valuation multiples (P/S 0.68, P/B 0.73), the stock faces headwinds from persistent losses and negative cash flow. Analyst consensus is cautious with a $7.25 price target below current levels, suggesting limited near-term upside despite recent positive momentum.
Goldman Sachs (GS) trades at $1,055.18, down 0.07% on the day, with a bullish technical outlook supported by moving averages and a neutral RSI. The company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $17.55 exceeding expectations. Revenue growth accelerated to $58.28 billion in 2025, and net income margin improved to 29.89%. Recent news highlights GS's role in leading high-profile IPOs, including Anthropic, signaling robust investment banking momentum.
The stock presents a favorable risk-reward profile with a consensus price target of $1,080, implying modest upside. Strengths include earnings momentum and leadership in M&A, but risks involve volatile cash flows and macroeconomic sensitivity. Analyst sentiment is mixed with 40% buy ratings, suggesting cautious optimism amid execution challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About American Well Corp
American Well Corp is a telehealth company enabling digital delivery of care for its customers. Its platform, Amwell, digital care delivery solution that equips health systems, health plans, government, and innovator clients with the tools to enable new models of care for their patients and members enabling care delivery across the full healthcare continuum - from primary and urgent care in the home to high acuity specialty consults, such as telestroke and telepsychiatry, in the hospital. It provides both on-demand and scheduled consultations. Its Health Plan Programs include Virtual Primary Care, Musculoskeletal Care, Dermatology Care, and Chronic Care among others and its Health System Modules include Acute Behavioral Health, ED Triage, Pediatrics and Telestroke among others.
Read more on AMWL →About Goldman Sachs Group Inc
The Goldman Sachs Group, Inc., a bank holding company, is a global investment banking and securities firm specializing in investment banking, trading and principal investments, asset management and securities services. The Company provides services to corporations, financial institutions, governments, and high-net worth individuals.
Read more on GS →
